Cite

HARVARD Citation

    Kalfus, I. et al. (n.d.). Clinical Safety of RHB‐105: A Novel Rifabutin Based Triple Therapy for the Treatment ofHelicobacter pyloriInfection. American journal of gastroenterology. p. . [Online]. 
  
Back to record